The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
9 November 2009
Employment effect (start)
1 January 2010
Foreseen end date
30 April 2010
Description
On 9 November 2009, Denmark-based manufacturer of insulin Novo Nordisk announced the closure of the factory in Kalundborg where 100 jobs will be cut. Further 230 employees will be relocated to other factories. The factory in Kalundbord has 2,100 employees and Novo employs 5,600 people in Denmark.
Sources
10 November 2009: politiken.dk
Citation
Eurofound (2009), Novo Nordisk, Closure in Denmark, factsheet number 69918, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/69918.